MedPath

Topical Steroid Treatment After Posterior Lamellar Corneal Transplantation

Not Applicable
Withdrawn
Conditions
Endothelial Dystrophy
Secondary Bullous Keratopathy
Posterior Lamellar Keratoplasty
Descemet's Stripping Endothelial Keratoplasty
Interventions
Drug: Weak steroid (Flurolon, Allergan)
Drug: Potent steroid (Maxidex, Alcon)
Registration Number
NCT01682421
Lead Sponsor
Aarhus University Hospital
Brief Summary

After corneal transplantation, topical corticosteroids are used to reduce the risk of rejection.

However, the optimal postoperative treatment regimen is unknown. In most cases, a topical steroid is administered for at least 6 months after surgery, but it remains to be determined whether potent steroids offer better protection than weak steroids. Also, the length of the treatment is debated.

Since the use of steroids is not without potential serious ocular side effects, it is of considerable importance to investigate these problems.

The study aims to examine the frequency of rejection episodes after posterior lamellar keratoplasty; specifically comparing a short course of potent steroids versus a long course of weak steroids.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Patients treated for primary or secondary corneal endothelial failure at the department of ophthalmology, Aarhus University Hospital
Exclusion Criteria
  • Not fulfilling the above

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Weak steroidWeak steroid (Flurolon, Allergan)Initial treatment with dexamethasone 6x per day for two weeks, followed by Fluorometholone 4x per day for 2 months, 3x per day for 2 months, 2x per day for 2 months, and finally 1x per day continually during 2 years.
Potent steroidPotent steroid (Maxidex, Alcon)Initially Dexamethasone 6x per day for 2 weeks followed by 4x per day for one month, 3x per day for one month, 2x per day for one month, and finally 1x per day for one month - giving a total of 4,5 months of steroid treatment.
Primary Outcome Measures
NameTimeMethod
Freedom from rejection2 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Ophthalmology, Aarhus Universtity Hospital

🇩🇰

Aarhus, Denmark

© Copyright 2025. All Rights Reserved by MedPath